
Donald J. Trump
@realDonaldTrump
May 11, 2025, 10:22 PM UTC
For many years the World has wondered why Prescription Drugs and Pharmaceuticals in the United States States of America were SO MUCH HIGHER IN PRICE THAN THEY WERE IN ANY OTHER NATION, SOMETIMES BEING FIVE TO TEN TIMES MORE EXPENSIVE THAN THE SAME DRUG, MANUFACTURED IN THE EXACT SAME LABORATORY OR PLANT, BY THE SAME COMPANY??? It was always difficult to explain and very embarrassing because, in fact, there was no correct or rightful answer. The Pharmaceutical/Drug Companies would say, for years, that it was Research and Development Costs, and that all of these costs were, and would be, for no reason whatsoever, borne by the “suckers” of America, ALONE. Campaign Contributions can do wonders, but not with me, and not with the Republican Party. We are going to do the right thing, something that the Democrats have fought for many years. Therefore, I am pleased to announce that Tomorrow morning, in the White House, at 9:00 A.M., I will be signing one of the most consequential Executive Orders in our Country’s history. Prescription Drug and Pharmaceutical prices will be REDUCED, almost immediately, by 30% to 80%. They will rise throughout the World in order to equalize and, for the first time in many years, bring FAIRNESS TO AMERICA! I will be instituting a MOST FAVORED NATION’S POLICY whereby the United States will pay the same price as the Nation that pays the lowest price anywhere in the World. Our Country will finally be treated fairly, and our citizens Healthcare Costs will be reduced by numbers never even thought of before. Additionally, on top of everything else, the United States will save TRILLIONS OF DOLLARS. Thank you for your attention to this matter. MAKE AMERICA GREAT AGAIN!
2231 Replies6364 Reposts21190 Likes
Trump Cuts Drug Prices
SUMMARY
Trump's plan to reduce prescription drug prices by 30-80% may negatively impact pharmaceutical stocks
TRUMP'S ATTITUDE
Determined and confident, with a sense of righteousness
FULL COMMENTARY
Historically, Trump's statements on reducing drug prices have led to increased market volatility and decreased stock prices for pharmaceutical companies. This executive order, aimed at reducing prescription drug prices, may lead to a decline in revenue and profitability for these companies, resulting in a bearish market sentiment. The implementation of a most favored nation's policy could also lead to increased regulatory scrutiny and potential changes in the business models of pharmaceutical companies, further exacerbating market uncertainty. Additionally, the potential savings of trillions of dollars for the United States could lead to increased competition and pricing pressures, negatively impacting the stock prices of pharmaceutical companies. However, it's essential to note that the actual impact will depend on the specifics of the executive order and how it is implemented, as well as the responses of pharmaceutical companies and other stakeholders.
Analysis generated for Stock Market on: May 11, 2025, 11:50 PM UTC